Retension Pharmaceuticals, Inc. RTSN
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.49M | 16.29M | 18.90M | 18.90M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 2.63M | 316.20K | 2.54M | 2.54M | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 16.13M | 16.61M | 21.45M | 21.45M | |
|
|
|||||
| Total Current Assets | 16.13M | 16.61M | 21.45M | 21.45M | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 16.13M | 16.61M | 21.45M | 21.45M | |
|
|
|||||
| Total Accounts Payable | 2.79M | 1.55M | 775.90K | 775.90K | |
| Total Accrued Expenses | 83.30K | 88.80K | 136.30K | 136.30K | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 2.88M | 1.64M | 912.20K | 912.20K | |
|
|
|||||
| Total Current Liabilities | 2.88M | 1.64M | 912.20K | 912.20K | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 2.88M | 1.64M | 912.20K | 912.20K | |
|
|
|||||
| Common Stock & APIC | 918.20K | 770.40K | 532.30K | 532.30K | |
| Retained Earnings | -15.84M | -13.97M | -8.32M | -8.32M | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -14.92M | -13.20M | -7.78M | -7.78M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 28.17M | 28.17M | 28.32M | 28.32M | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 28.17M | 28.17M | 28.32M | 28.32M | |
|
|
|||||
| Total Common Equity | -14.92M | -13.20M | -7.78M | -7.78M | |
| Total Preferred Equity | 28.17M | 28.17M | 28.32M | 28.32M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 13.25M | 14.97M | 20.53M | 20.53M | |
|
|
|||||